Reduce Interpretation Gaps Before They Become Regulatory Questions
RegXpertPRO turns interpretation-heavy analytical guidance into structured tools and review-ready decision support.
RegXpertPRO turns interpretation-heavy analytical guidance into structured tools and review-ready decision support.
Most regulatory deficiencies do not arise because data is missing.
They arise because:
The issue is often not the quality of data.
It is the gap between guidance, interpretation, and execution.
Structured tools for repeatable analytical decision steps
For interpretation-heavy workflows where guidance must be applied consistently in real work.
Current tools include:
Interpretation support before submission or deficiency response.
For teams that already have data, but need stronger analytical narrative, justification, and alignment before submission.
Support areas include:
Are your customers raving about you on social media? Share their great stories to help turn potential customers into loyal ones.
Built for analytical and regulatory CMC teams who need consistent, repeatable decision support at the point where guidance meets real data.
Browser-based f2 support for immediate - release dissolution profile comparison.
Paste dissolution profile data from Excel and use the Free Basic f2 Calculation for a quick user-selected preview.
Unlock the Paid Pathway-specific Assessment to apply FDA and EMA/ ICH M9-aligned eligibility criteria, auto-select applicable timepoints, and generate f2 outputs with reasoning.
Best for:
Desktop review, Excel-based workflows, printable reports, and structured internal documentation.
Mobile-friendly f2 decision support for review discussions and point-of-need use for immediate - release dissolution profile comparison.
Designed for moments when the teams need quick FDA, EMA/ ICH M9-guidance aligned time-point selection and f2 interpretation without reopening spreadsheets or rechecking guidance during discussion.
Best for:
meeting-time discussions, mobile access, and quick dissolution similarity review.
A quick calculator for pharmacopoeial system precision checks.
Designed to support consistent interpretation of maximum permitted % RSD for system suitability for Assay test, based on the method setup and pharmacopoeial expectations.
Best for:
assay system precision, System suitability test (SST) limit discussions and quick reviewer checks.
This work is most useful when:
The objective is not more data.
It is clearer regulatory interpretation, explicit scientific narrative, and better-aligned documentation.
Guidance documents define expectations.
But teams still need to interpret and apply them repeatedly across products, projects, and submissions.
Guidance Operationalization means translating that logic intro structured execution criteria, so work becomes:
Pocket f2 Select is one example of this approach in practice.
And the same principle also supports stronger analytical interpretation in reports, submissions, and deficiency responses.

Founded by a pharmaceutical CMC and dissolution specialist with 23+ years of experience across method development and specifications, dissolution evaluation, scientific justification, and regulatory deficiency responses.
The focus is simple: help pharma teams reduce interpretation gaps before they turn into review questions, delays, or avoidable deficiencies.
For Pharma professionals who want early visibility into structured tools, regulatory deep dives, and pilot cohorts
Members receive:
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.